资讯

Health and Me on MSN2 天
FDA Mandates ADHD Drug Labels To Warn Of Weight Loss Risk
The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...
Collegium Pharmaceutical: Stock Deserves A 'Buy' Call On Undervaluation Of ADHD Drug
Collegium's new ADHD drugs may allow the company to grow revenues faster and pay off debt faster. Click here to find out why ...
FDA to revise labeling of ADHD medication to indicate weight loss risk
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
US FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Science Daily4 天
Is that really ADHD? Why flawed trials may be misleading millions
Researchers reviewing nearly 300 top-tier ADHD drug trials found that half skipped the rigorous, expert-led evaluations needed to rule out other conditions like depression or schizophrenia. With ...
US FDA to revise label of ADHD stimulants to add weight loss risk in patients younger than 6
The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants to treat ...
Independent Journal Review22 小时Opinion
SHERI FEW: It’s Time To Make Our Children Healthy Again, Starting With ADHD Reform
When combined, a subjective list of common childhood behaviors (fidgeting, losing things, distractibility, not following ...
More than meds: why easier access to ADHD treatment has to be part of a whole-system approach
Increasing access to ADHD diagnosis and medication is a good move. But it shouldn’t be the whole plan to address a condition ...
KSL4 天
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...